How Does Cost Factor into CDMO Selection and Outsourcing Approach?

110

INTRODUCTION
A recent analysis of ISR data on factors driving CDMO selection for small molecule drug substance over the prior five years showed that the importance of Low cost varied from year to year (1). The attribute earned an average five-year ranking of 5.2 out of the 28 different CDMO characteristics presented to survey participants, making it the sixth highest ranking selection metric. Contract manufacturer attributes such as Proven ability to manufacture small molecule API, Reliable, on-time delivery, Strong regulatory track record, Has capacity to meet our demands and Prior positive experience with the service provider all averaged a higher combined ranking when aggregating ISR’s CDMO Benchmarking data from 2018 to 2022. While attributes like Track record for meeting quality performance metrics and Scientific knowledge also made appearances in the top-five selection metrics during the timeframe. This article will further explore how cost influences CDMO selection and what other factors are at play.